IN2012DN01577A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01577A IN2012DN01577A IN1577DEN2012A IN2012DN01577A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A IN 1577DEN2012 A IN1577DEN2012 A IN 1577DEN2012A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A
- Authority
- IN
- India
- Prior art keywords
- relates
- present
- attenuated
- cells
- preparation
- Prior art date
Links
- 241000700605 Viruses Species 0.000 abstract 4
- 241000287828 Gallus gallus Species 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 210000002257 embryonic structure Anatomy 0.000 abstract 2
- 230000002255 enzymatic effect Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09305690 | 2009-07-21 | ||
| US26429909P | 2009-11-25 | 2009-11-25 | |
| PCT/EP2010/004478 WO2011009613A1 (en) | 2009-07-21 | 2010-07-21 | Enzymatic composition for the digestion of chicken embryos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01577A true IN2012DN01577A (ja) | 2015-06-05 |
Family
ID=43498784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1577DEN2012 IN2012DN01577A (ja) | 2009-07-21 | 2010-07-21 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120190100A1 (ja) |
| EP (1) | EP2456461A1 (ja) |
| JP (1) | JP2012533311A (ja) |
| KR (1) | KR20120089245A (ja) |
| CN (1) | CN102939100A (ja) |
| AU (1) | AU2010275764A1 (ja) |
| CA (1) | CA2768562A1 (ja) |
| IN (1) | IN2012DN01577A (ja) |
| MX (1) | MX2012000979A (ja) |
| RU (1) | RU2012106760A (ja) |
| SG (1) | SG178090A1 (ja) |
| TW (1) | TW201109440A (ja) |
| WO (1) | WO2011009613A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011316730B2 (en) * | 2010-10-11 | 2015-12-10 | Abbvie Bahamas Ltd. | Processes for purification of proteins |
| ES2701763T3 (es) * | 2012-07-09 | 2019-02-25 | Hoffmann La Roche | Proteasa neutra producida de forma recombinante procedente de Paenibacillus polymyxa |
| CN104818238B (zh) * | 2015-03-26 | 2019-12-20 | 四川农业大学 | 一种鸡肠上皮细胞分离培养方法 |
| CN113750224B (zh) * | 2015-05-19 | 2024-04-30 | 科学蛋白实验室有限责任公司 | 在生产胰酶过程中减少或灭活病毒和微生物内容物的方法 |
| CN105316309A (zh) * | 2015-12-04 | 2016-02-10 | 广州赛莱拉干细胞科技股份有限公司 | 一种消化酶组合物及成纤维细胞和饲养层细胞的制备方法 |
| CN109957545A (zh) * | 2017-12-26 | 2019-07-02 | 江苏艾尔康生物医药科技有限公司 | 一种消化rpe细胞的方法 |
| KR102267837B1 (ko) * | 2018-01-19 | 2021-06-22 | 코오롱생명과학 주식회사 | 재조합 백시니아 바이러스 및 이를 포함하는 약학 조성물 |
| WO2019212921A1 (en) * | 2018-04-29 | 2019-11-07 | Regenxbio Inc. | Scalable clarification process for recombinant aav production |
| CN109943520B (zh) * | 2019-03-08 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用 |
| CN111117947B (zh) * | 2020-01-09 | 2022-03-08 | 电子科技大学 | 一种鲤科鱼类肝细胞的快速分离方法 |
| CN112458040B (zh) * | 2020-12-23 | 2022-07-05 | 四川农业大学 | 一种成年牦牛瘤胃上皮细胞的分离培养方法 |
| CN113136412A (zh) * | 2021-04-22 | 2021-07-20 | 浙江珂瑞康生物医疗科技有限公司 | 用于含可溶性蛋白生物医用材料的生物负载测定处理液 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4072565A (en) * | 1974-11-04 | 1978-02-07 | The Dow Chemical Company | Production of viruses in tissue culture without use of serum |
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| FR2643817B1 (fr) | 1989-03-06 | 1993-12-17 | Transgene Sa | Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus |
| GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
| GB9001641D0 (en) | 1990-01-24 | 1990-03-21 | Imp Cancer Res Tech | Compounds |
| FR2668064B1 (fr) | 1990-10-23 | 1994-12-16 | Transgene Sa | Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne. |
| WO1994029471A1 (en) | 1993-06-10 | 1994-12-22 | Genetic Therapy, Inc. | Adenoviral vectors for treatment of hemophilia |
| FR2710536B1 (fr) | 1993-09-29 | 1995-12-22 | Transgene Sa | Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire. |
| FR2751879B1 (fr) | 1996-07-30 | 1998-10-30 | Transgene Sa | Composition pharmaceutique contre les tumeurs et infections a papillomavirus |
| FR2766091A1 (fr) | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
| FR2777570A1 (fr) | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
| EP1434858B2 (en) | 2002-09-05 | 2018-12-19 | Bavarian Nordic A/S | Method for the amplification of a poxvirus under serum free conditions |
| FR2855758B1 (fr) | 2003-06-05 | 2005-07-22 | Biomerieux Sa | Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique |
| EP1897938B9 (en) | 2003-07-21 | 2011-08-31 | Transgene SA | Polypeptide having an improved cytosine deaminase activity |
| AU2003267841A1 (en) * | 2003-09-29 | 2005-04-14 | Seong Jun Yoon | Highly bioactive and productive chicken embryo extract and method for preparation thereof |
| AU2005272681B2 (en) * | 2004-08-13 | 2009-11-19 | University Of Georgia Research Foundation, Inc. | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
| EP1807508A4 (en) * | 2004-11-05 | 2008-03-12 | Us Gov Health & Human Serv | METHODS FOR PREPARING CELLS AND VIRUSES |
| AU2006243810B2 (en) | 2005-04-29 | 2012-06-07 | Monash University | A method for producing stem cells or stem cell-like cells from mammalian embryos |
| EP2013229A2 (en) | 2006-04-21 | 2009-01-14 | Transgene S.A. | Hpv-18-based papillomavirus vaccine |
| EP2530161B1 (en) | 2006-06-20 | 2018-03-28 | Transgene SA | Process for producing poxviruses and poxvirus compositions |
| GB0613756D0 (en) * | 2006-07-12 | 2006-08-23 | Univ Sheffield | Cell culture medium |
-
2010
- 2010-07-21 IN IN1577DEN2012 patent/IN2012DN01577A/en unknown
- 2010-07-21 MX MX2012000979A patent/MX2012000979A/es not_active Application Discontinuation
- 2010-07-21 CN CN2010800583217A patent/CN102939100A/zh active Pending
- 2010-07-21 US US13/386,168 patent/US20120190100A1/en not_active Abandoned
- 2010-07-21 CA CA2768562A patent/CA2768562A1/en not_active Abandoned
- 2010-07-21 KR KR1020127004441A patent/KR20120089245A/ko not_active Application Discontinuation
- 2010-07-21 WO PCT/EP2010/004478 patent/WO2011009613A1/en active Application Filing
- 2010-07-21 RU RU2012106760/10A patent/RU2012106760A/ru not_active Application Discontinuation
- 2010-07-21 JP JP2012520954A patent/JP2012533311A/ja not_active Withdrawn
- 2010-07-21 SG SG2012004883A patent/SG178090A1/en unknown
- 2010-07-21 EP EP20100735215 patent/EP2456461A1/en not_active Withdrawn
- 2010-07-21 TW TW99124030A patent/TW201109440A/zh unknown
- 2010-07-21 AU AU2010275764A patent/AU2010275764A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2456461A1 (en) | 2012-05-30 |
| AU2010275764A2 (en) | 2012-03-15 |
| US20120190100A1 (en) | 2012-07-26 |
| CN102939100A (zh) | 2013-02-20 |
| RU2012106760A (ru) | 2013-08-27 |
| MX2012000979A (es) | 2012-06-08 |
| SG178090A1 (en) | 2012-03-29 |
| WO2011009613A1 (en) | 2011-01-27 |
| KR20120089245A (ko) | 2012-08-09 |
| AU2010275764A1 (en) | 2012-03-15 |
| CA2768562A1 (en) | 2011-01-27 |
| TW201109440A (en) | 2011-03-16 |
| JP2012533311A (ja) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01577A (ja) | ||
| BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
| CY1121159T1 (el) | Μη-ενσωματουμενοι λεντiϊικοι φορεις | |
| WO2011000566A3 (en) | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections | |
| PH12015501953A1 (en) | Substituted nucleotide analogs | |
| CR20110641A (es) | Metodo para la produccion y purificacion de orthopoxvirus | |
| MY183385A (en) | Production of polio virus at high titers for vaccine production | |
| NZ629582A (en) | Production of fmdv-resistant livestock by allele substitution | |
| CY1114356T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
| MXPA06013411A (es) | Procedimiento para la produccion de una vacuna contra la influenza. | |
| MX2007007889A (es) | Rescate del virus de influenza. | |
| EA201190259A1 (ru) | Противовирусные соединения | |
| MX349119B (es) | Vacuna de virus de dengue inactivado. | |
| PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
| SG179082A1 (en) | Method for the preparation of an influenza virus | |
| NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
| WO2011007339A3 (en) | Chimeric foot and mouth disease viruses | |
| WO2009080806A3 (en) | Modified influenza virus | |
| WO2009135199A3 (en) | Vaccine compositions and methods | |
| WO2013058484A3 (ko) | 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물 | |
| MX2010005701A (es) | Metodo para producir cepa viral vacunal de un virus de la familia reoviridae. | |
| MX339731B (es) | Vacunas contra la bronquitis infecciosa derivadas de cepas similares a qx-bi. | |
| WO2009126308A3 (en) | Compositions and methods for vaccine and virus production | |
| MX2011002309A (es) | Anticuerpos de aves especificos para virus de influenza y metodos tecnologicamente sencillos de su fabricacion y uso. | |
| WO2014008475A3 (en) | Compositions and methods related to viral vaccines |